FR2396019A1 - Nouveaux glycopeptides acetyles hydrosolubles extraits de corps microbiens lyses de pseudomonas aeruginosa, procede de preparation et application a titre de medicaments - Google Patents

Nouveaux glycopeptides acetyles hydrosolubles extraits de corps microbiens lyses de pseudomonas aeruginosa, procede de preparation et application a titre de medicaments

Info

Publication number
FR2396019A1
FR2396019A1 FR7720319A FR7720319A FR2396019A1 FR 2396019 A1 FR2396019 A1 FR 2396019A1 FR 7720319 A FR7720319 A FR 7720319A FR 7720319 A FR7720319 A FR 7720319A FR 2396019 A1 FR2396019 A1 FR 2396019A1
Authority
FR
France
Prior art keywords
pseudomonas aeruginosa
antiinflammatories
prepn
immunostimulant
antibacterials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7720319A
Other languages
English (en)
Other versions
FR2396019B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cassenne Laboratoires
Original Assignee
Cassenne Laboratoires
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassenne Laboratoires filed Critical Cassenne Laboratoires
Priority to FR7720319A priority Critical patent/FR2396019A1/fr
Publication of FR2396019A1 publication Critical patent/FR2396019A1/fr
Application granted granted Critical
Publication of FR2396019B1 publication Critical patent/FR2396019B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Nouveaux glycopeptides acétylés hydrosolubles extraits de corps microbiens lyses, caractérisés en ce que les microorganismes sont constitués par des Pseudomonas Aeruginosa, en ce que lesdits glycopeptides ont un poids moléculaire apparent compris entre 500 et 200 000, en ce qu'ils renferment au moins 20 % de substances à pouvoir biurétogène et au moins 25 % d'oses neutres, ne renferment pas d'acide diaminopimélique et présentent un maximum d'absorption dans l'Ultra-Violet à environ 210 m mu . Procédé de préparation et application à titre de médicaments de ces nouveaux glycopeptides.
FR7720319A 1977-07-01 1977-07-01 Nouveaux glycopeptides acetyles hydrosolubles extraits de corps microbiens lyses de pseudomonas aeruginosa, procede de preparation et application a titre de medicaments Granted FR2396019A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7720319A FR2396019A1 (fr) 1977-07-01 1977-07-01 Nouveaux glycopeptides acetyles hydrosolubles extraits de corps microbiens lyses de pseudomonas aeruginosa, procede de preparation et application a titre de medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7720319A FR2396019A1 (fr) 1977-07-01 1977-07-01 Nouveaux glycopeptides acetyles hydrosolubles extraits de corps microbiens lyses de pseudomonas aeruginosa, procede de preparation et application a titre de medicaments

Publications (2)

Publication Number Publication Date
FR2396019A1 true FR2396019A1 (fr) 1979-01-26
FR2396019B1 FR2396019B1 (fr) 1980-03-07

Family

ID=9192865

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7720319A Granted FR2396019A1 (fr) 1977-07-01 1977-07-01 Nouveaux glycopeptides acetyles hydrosolubles extraits de corps microbiens lyses de pseudomonas aeruginosa, procede de preparation et application a titre de medicaments

Country Status (1)

Country Link
FR (1) FR2396019A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0012552A1 (fr) * 1978-12-04 1980-06-25 Merck & Co. Inc. Hétéropolysaccharides produits par des bactéries et produits dérivés, leur préparation et la culture lyophylisée des bactéries
US4326052A (en) * 1978-12-04 1982-04-20 Merck & Co., Inc. Deacetylated polysaccharide S-60
US4326053A (en) * 1978-12-04 1982-04-20 Merck & Co., Inc. Polysaccharide S-60 and bacterial fermentation process for its preparation
US4377636A (en) * 1979-06-08 1983-03-22 Merck & Co., Inc. Polysaccharide S-60 and bacterial fermentation process for its preparation
US4385123A (en) * 1979-06-08 1983-05-24 Merck & Co., Inc. Deacetylated polysaccharide S-60
FR2540136A1 (fr) * 1983-01-28 1984-08-03 Roussel Uclaf Nouveau procede de preparation d'acylglycoproteines immunostimulantes extraites de klebsiella pneumoniae, compositions pharmaceutiques et procede de lutte contre les maladies allergiques
EP0438747A1 (fr) * 1989-12-22 1991-07-31 SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. Composition stable d'antibiotiques glycopeptidiques
US8143212B2 (en) 2002-11-18 2012-03-27 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0012552A1 (fr) * 1978-12-04 1980-06-25 Merck & Co. Inc. Hétéropolysaccharides produits par des bactéries et produits dérivés, leur préparation et la culture lyophylisée des bactéries
US4326052A (en) * 1978-12-04 1982-04-20 Merck & Co., Inc. Deacetylated polysaccharide S-60
US4326053A (en) * 1978-12-04 1982-04-20 Merck & Co., Inc. Polysaccharide S-60 and bacterial fermentation process for its preparation
US4377636A (en) * 1979-06-08 1983-03-22 Merck & Co., Inc. Polysaccharide S-60 and bacterial fermentation process for its preparation
US4385123A (en) * 1979-06-08 1983-05-24 Merck & Co., Inc. Deacetylated polysaccharide S-60
FR2540136A1 (fr) * 1983-01-28 1984-08-03 Roussel Uclaf Nouveau procede de preparation d'acylglycoproteines immunostimulantes extraites de klebsiella pneumoniae, compositions pharmaceutiques et procede de lutte contre les maladies allergiques
EP0115988A1 (fr) * 1983-01-28 1984-08-15 Roussel-Uclaf Nouveau procédé de préparation d'acylglycoprotéines immunostimulantes extraites de Klebsiella pneumoniae, compositions pharmaceutiques antiallerqiques
EP0438747A1 (fr) * 1989-12-22 1991-07-31 SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. Composition stable d'antibiotiques glycopeptidiques
US8143212B2 (en) 2002-11-18 2012-03-27 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections

Also Published As

Publication number Publication date
FR2396019B1 (fr) 1980-03-07

Similar Documents

Publication Publication Date Title
ES2157958T3 (es) Uso de venlafaxina o de un compuesto de ariloxipropanamina para la preparacion de un medicamento para el tratamiento de la incontinencia urinaria.
SE8501723D0 (sv) Preparation att anvendas vid behandling av ledinflammation
IL121126A0 (en) Method of increasing expression of molecular chaperon by an eukarytic cell
BR9713479A (pt) Preparação farmacêutica compreendendo ácido eicosapentaenóico e/ou ácido estearidÈnico.
BR9710689A (pt) Processo para tratar diarr-ia aguda e para proporcionar terapia a um mam¡fero tendo diarr-ia e prepara-Æo terap-utica para redu-Æo de sintomas de diarr-ia
CA2185983A1 (fr) Methode pour extraire des ingredients biologiquement actifs a partir d'une combinaison de plantes medecinales et les purifier; composition de l'extrait
FR2396019A1 (fr) Nouveaux glycopeptides acetyles hydrosolubles extraits de corps microbiens lyses de pseudomonas aeruginosa, procede de preparation et application a titre de medicaments
GR3017128T3 (en) Treatment of hiv infections and compounds useful therein.
HK69992A (en) Manufacture of tetra-alkyl ethenylidene bis phosphonates and use thereof in pha rmaceutical compositions
EP1285667A3 (fr) Solutions pharmaceutiques injectables contenant du paracétamol et des associations de paracétamol avec d' autres substances actives
AU3396695A (en) Improvements in or relating to contrast agents
DK165903C (da) Farmaceutisk praeparat mod acne
DK0737072T3 (da) Anvendelse af simple og konjugerede dekstraner ved fremstilling af et medikament til at forhindre eller nedsætte risikoen f
PT795604E (pt) Estirpes de bacterias com metabolismo alterado de acidos biliares e sua utilizacao
ES522637A0 (es) Procedimiento para la preparacion de nuevas sustancias ws 6049.
PH27214A (en) N-2,3-butadienyl tri and tetraaminoalkane derivatives
ES2032323T3 (es) Un procedimiento para la produccion de una preparacion antifungica formadora de pelicula.
JPS5729285A (en) Superoxide dismutase and its preparation
EP0309810A3 (fr) Agent épaississant
AU4738500A (en) Improved method for treating mammals with modified mammalian blood
FR2396018A1 (fr) Nouveaux glycopeptides acetyles hydrosolubles extraits de corps microbiens lyses d'escherichia coli, procede de preparation et application a titre de medicaments de ces produits
DE3268159D1 (en) Medicaments based on algae, and formulations thereof
NO920255D0 (no) Podofyllotoksinpreparat som inneholder triglyserider
RU97122076A (ru) Рибосомная фракция и композиция, ее содержащая
Migasena et al. Mebendazole, tetrachlorethylene and pyrantel pamoate in the treatment of hookworm infection

Legal Events

Date Code Title Description
ST Notification of lapse